SECsense Logo

Lixte Biotechnology 8-K Report: Key Updates and Stock Insights

$LIXT
Form 8-K
Filed on: 2025-02-21
Source
Lixte Biotechnology 8-K Report: Key Updates and Stock Insights

Based on the provided XML section of the financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Name: Lixte Biotechnology Holdings, Inc.
  • CIK (Central Index Key): 0001335105
  • Incorporation State: Delaware (DE)
  • IRS Employer Identification Number (EIN): 20-2903526
  • Address: 680 East Colorado Boulevard, Suite 180, Pasadena, CA 91101
  • Contact Number: (631) 830-7092
  1. Report Type:
  • The report is an 8-K, which is a filing used to report major events that shareholders should know about.
  1. Filing Date:
  • The filing date is February 19, 2025.
  1. Stock Information:
  • Common Stock Ticker: LIXT (traded on NASDAQ)
  • Warrant to Purchase Common Stock Ticker: LIXTW (traded on NASDAQ)
  1. Period of Reporting:
  • The reporting period is February 19, 2025.
  1. Securities Information:
  • The report mentions both Common Stock and Warrants to purchase Common Stock, indicating that the company may be involved in capital-raising activities or corporate finance maneuvers.
  1. XBRL Data Structure:
  • The document is structured using XBRL (eXtensible Business Reporting Language), providing standardized financial information that can be easily processed and analyzed.
  1. Measurement Units:
  • Financial figures are represented in USD (United States Dollars) as well as in Shares.

Overall, this section indicates a corporate filing related to Lixte Biotechnology Holdings, highlighting key corporate identifiers, stock and warrant information, and the context of the filing. Given that it is an 8-K, it may contain significant updates or changes in company operations, which would be critical for investors and stakeholders to analyze further.